Notice ID: 67fe94037dad444fbdc7cdb328b06978Special Notice
Amendment_MSPV Q4 FY26 Open Market
Responses closed . Full description on SAM.gov.
Description
1.The purpose of this amendment is publish answers to offeror submitted questions. Please continuation page for all
answers.
2.This amendment extends the closing date and time of the solicitation.
Completed quote sheets must be submitted to the Contracting Officer listed below NLT 4:00pm CST, 10/19/2026.
3.Please see continuation page for all items removed from the quote sheet.
4.No additional questions will be accepted at this time.
Overview
Agency:
Department of Veterans Affairs
Office:RPO EAST (36C24E)
Posted:October 15, 2026
NAICS:339113: Surgical Appliance and Supplies Manufacturing
Last Updated:Oct 28, 2026
First published:
Last updated on SAM.gov:
PSC:6515: MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
Set-Aside:Veteran-Owned Small Business Set-Aside (specific to Department of Veterans Affairs)
Type:Special Notice
Place of Performance:Pittsburgh, Pennsylvania, 15215
Award Overview
Possible prior contracts
Sign in to see possible prior contracts for this requirement (matched by agency, NAICS and place of performance; not confirmed).
Contacts
Contracting Officer
Primary Contact
Rashaun Thomas
Documents
Files (7)
- Download
S02_Draft Quote Sheet_MSPV Q4 FY26 Open Market_36C24E26Q0058.zip
469 KBAdded in Combined Synopsis/Solicitation version 1Posted - Download
S02_Attachment B.1- Sample Alternate ADL Accounting for Authorized Wholesaler.docx
17 KBAdded in Combined Synopsis/Solicitation version 1Posted - Download
S02_Attachment B - Sample Authorized Distributor Letter.docx
21 KBAdded in Combined Synopsis/Solicitation version 1Posted - Download
S02_RFQ amendment_MSPV Q4 FY26 Open Market_36C24E26Q0058 0001.pdf
368 KBAdded in Special Notice version 2Posted - Download
S02_RFQ_MSPV Q4 FY26 Open Market_36C24E26Q0058.pdf
665 KBAdded in Combined Synopsis/Solicitation version 1Posted - Download
S02_Final Quote Sheet_MSPV Q4 FY26 Open Market_36C24E26Q00583.zip
356 KBAdded in Special Notice version 2Posted - Download
S02_Combined Synopsis-Solicitation Notice_MSPV Q4 FY26 Open Market_36C24E26Q0058_1.pdf
251 KBAdded in Combined Synopsis/Solicitation version 1Posted
Lifecycle
- 1Version 1Combined Synopsis/Solicitation
MSPV Q4 FY26 Open Market
- 2Version 2Special NoticeCurrent
Type changed from Combined Synopsis/Solicitation to Special Notice
Amendment_MSPV Q4 FY26 Open Market
Similar Opportunities
Title | Phase | Agency | NAICS | Set Aside | Posted | Deadline | Location |
|---|---|---|---|---|---|---|---|
THIS IS A COMBINED SYNOPSIS AND SOLICITATION NOTICE OF TIERED EVALUATIONS: This procurement action for medical/surgical prime vendor (MSPV) items is set-aside based on an order of priority as established in 38 U.S.C. 8127. TIERED EVALUATIONS INCLUDING LARGE BUSINESS CONCERNS: This solicitation is being issued as a tiered evaluation with the following tiers: (1) SDVOSB concerns, (2) VOSB concerns, (3) small business concerns with HUBZone small business concerns and 8(a) participants having priority; and (4) large business concerns. The Department of Veterans Affairs (VA) is publishing this Request for Quotes (RFQ) on September 15, 2026, for the acquisition of consumable commodities in support of the Medical/Surgical Prime Vendor (MSPV) Program catalogue. The MSPV Program is a partnering effort between Veterans Healthcare Administration (VHA) and the VA Office of Acquisition, Logistics & Construction (OALC) to deliver a national strategic sourcing solution that combines a formulary approach with electronic cataloging and ordering of a wide range of medical and surgical supplies for the Veterans Administration Medical Centers (VAMC) and related facilities. The establishment of Blanket Purchase Agreements (BPAs) is in direct support of this initiative and is a key element in the success of the MSPV Program, as the BPAs will provide the mechanism that will supply the types of supplies for distribution to all VHA facilities located in the United States (U.S.) and all U.S. Territories. In order to support the MSPV Program, the VA will establish BPAs for medical/surgical supplies through Open Market BPAs under FAR Part 12. This solicitation is structured as a tiered evaluation to maximize Service-Disabled Veteran-Owned Small Business and Veteran-Owned Small Business (SD/VOSB) participation. Quotations will be evaluated based on technical criteria and price. VHA clinicians will participate in evaluating all supplier quotations and awards will be made using comparative analysis. NOTE: All items are original equipment manufacturer products, and only the items listed can be quoted. We are not seeking “like” or substitute items. Quotes for items not listed by OEM number on the quote sheet will not be accepted. Please see Combined Synopsis/Solicitation Notice for full details of the solcitation. | Combined Synopsis | 339113 | Veteran-Owned Small Business Sole Source (VA only) | 09/15/2026 | 10/15/2026 | - | |
THIS IS A COMBINED SYNOPSIS AND SOLICITATION NOTICE OF TIERED EVALUATIONS: This procurement action for the Department of Veterans Affairs (VA) Medical/Surgical Prime Vendor (MSPV) Supplies Program and is set-aside based on an order of priority as established in 38 U.S.C. 8127. TIERED EVALUATIONS INCLUDING LARGE BUSINESS CONCERNS: This solicitation is being issued as a tiered evaluation with the following tiers: (1) SDVOSB concerns, (2) VOSB concerns, (3) small business concerns with HUBZone small business concerns and 8(a) participants having priority; and (4) large business concerns. The Department of Veterans Affairs (VA) is publishing this Request for Quotes (RFQ) on or about September 25, 2026, for the acquisition of consumable commodities in support of the Medical/Surgical Prime Vendor (MSPV) Program catalogue. The MSPV Program is a partnering effort between Veterans Healthcare Administration (VHA) and the VA Office of Acquisition, Logistics & Construction (OALC) to deliver a national strategic sourcing solution that combines a formulary approach with electronic cataloging and ordering of a wide range of medical and surgical supplies for the Veterans Administration Medical Centers (VAMC) and related facilities. The establishment of Blanket Purchase Agreements (BPAs) is in direct support of this initiative and is a key element in the success of the MSPV Program, as the BPAs will provide the mechanism that will supply the types of supplies for distribution to all VHA facilities located in the United States (U.S.) and all U.S. Territories. In order to support the MSPV Program, the VA will establish BPAs for medical/surgical supplies through Open Market BPAs under FAR Part 12. This solicitation is structured as a tiered evaluation to maximize Service-Disabled Veteran-Owned Small Business and Veteran-Owned Small Business (SD/VOSB) participation. Quotations will be evaluated based on technical criteria and price. VHA clinicians will participate in evaluating all supplier quotations and awards will be made using comparative analysis. In order for an authorized distributor/supplier to participate in the MSPV Program, the authorized distributor/supplier and the Prime Vendor shall establish a Commercial Agreement within 60 days of award. The Commercial Agreement will govern the terms and conditions of the authorized distributor/supplier relationship and will not contradict the underlying terms and conditions established by this BPA or the underlying MSPV Contract. See Statement of Work for further details. The MSPV Program recognizes that various NAICS codes may/can be used for this procurement. The standard/typical NAICS code for surgical/medical supplies manufacturing (not including medical instruments or equipment) is 339113. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.sam.gov. No paper copies of the presolicitation/solicitation will be available, and no telephone requests for paper copies of the presolicitation/solicitation will be accepted. Interested Quoters are advised to continuously check the URL for any changes to this solicitation. All responsible sources may submit a quote that, if timely received NLT the due date and time for quote submission, will be given full consideration. MSPV is seeking quotes from authorized sources (including manufacturers) for each of the items on the quote sheet. The quote sheet for submission is found as Attachment A - Quote Sheet_36C24E26Q0090_Neuro Patties_Fast Track_Q426_V1 and is the only acceptable quote sheet for submission. NOTE: All items are original equipment manufacturer products, and only the items listed can be quoted. MSPV is NOT seeking like or substitute items. Quotes for items not listed by OEM number on the quote sheet will not be accepted. If an item has been discontinued and a direct replacement is available, please provide that information to the Contracting Officer listed below. Be advised, the Government is not seeking substitute, equivalent, or like items at this time. Only direct replacements for discontinued items will be considered for this solicitation. If an item found within this solicitation classifies as a prosthetic item or is on another national-level VA contract vehicle please advise the Contracting Officer listed below. Any further questions may be directed to the Contracting Officer listed below. All questions and communications shall be in writing to the Contracting Officer at the email address listed below. Any revised/updated information received will be published as an amendment that revises/corrects the quote sheet. It is the burden of the quoter to continuously monitor this solicitation for any subsequent amendments. An Authorized Distributor Letter (ADL) from the Original Equipment Manufacturer (OEM) shall be included with all responses. The ADL from the OEM shall include each product(s) proposed authorizing the Quoter as a distributor for the proposed product(s). The letter must either state specific product(s) proposed or that the Quoter is an authorized distributor for all of OEM s products. The letter must expressly state that the Quoter is an authorized distributor for the MSPV BPA Program. This letter must be on the OEM s letterhead and contain the signature of an authorized official for the OEM. Additionally, the letter must be signed and dated within 90 days of the time the Contracting Officer receives it. See the Statement of Work included in the solicitation for further details. A sample ADL is included in this RFQ as Attachment B - Sample Authorized Distributor Letter_36C24E26Q0090 for reference only. Please ensure the verbiage in the ADL includes correct manufacturer and supplier information. See the Statement of Work for specific information regarding the ADL requirement. Completed and accurate quote sheets along with any other required documentation must be timely received no later than 12:00pm EDT on October 8, 2026. Any quote sheets received after this date may not be accepted. The below Contracting Officer is responsible for this solicitation and can be contacted as follows: Michael Pierson, Contracting Officer michael.pierson@va.gov See Attached Document: 36C24E26Q0090_Neuro Patties_Fast Track_Q426 Attachment A - Quote Sheet_36C24E26Q0090_Neuro Patties_Fast Track_Q426_V1 Attachment B - Sample Authorized Distributor Letter_36C24E26Q0090 | Combined Synopsis | 339113 | Service-Disabled Veteran-Owned Small Business Set-Aside | 09/24/2026 | 10/08/2026 | - | |
This is a SOURCES SOUGHT NOTICE only. Responses to this notice will be used for information and planning purposes. No quotes are being requested or accepted at this time with this notice. The Department of Veterans Affairs (VA), Procurement Operations East Region, Medical Surgical Prime Vendor (MSPV) Program has a VA-wide requirement for Textiles (Towels and Washcloths) that meet the Minimum Technical Requirements (MTR) on Attachment 1 MTR for Reusable Textile. The North American Industry Classification System (NAICS) code being considered for this procurement is 339113, Surgical Appliance and Supplies Manufacturing and the Product Service Code (PSC) is 6515, Medical and Surgical Instruments, Equipment and Supplies. The Small Business Size Standard is 800 employees. Potential Sources shall respond with their ability to provide Textiles meeting all Minimum Technical Requirements. Responses to this notice should include the following: Company Name Company s DUNS Company s Unique Entity Identifier (UEI) Company s Address Point of Contact Information (i.e. title, phone number and email address) Provide Proof of Authorization to Distribute Items from the Original Equipment Manufacturer (OEM) Country of Origin for Items Country Where Raw Materials are Sourced List All Certifications (ie USDA BioPreferred Program) Company s capability to meet this requirement and any pertinent information which demonstrates the company s ability to meet the requirements. Federal Supply Schedule contract number, within scope of this effort (if applicable). Company s type of business (small or large) and socioeconomic status whether Service Disable Veteran Owned, Veteran Owned, Hubzone, 8(a), Women Owned, Small Disadvantaged, etc. If applicable, Service-Disabled Veteran Owned Small Businesses (SDVOSB) and Veteran Owned Small Businesses (VOSB) must be verified by SBA. In addition to providing responses to numbers 1 12 above, interested companies must complete Attachment 2 Product Sourcing Request and Attachment 3 MSPV Bulk PSR Template to be considered a complete response. All responses shall be submitted via email no later than 3:00pm (EST) September 10, 2026 to Maureen Long at Maureen.Long2@va.gov. Simply responding as an interested party does not constitute your company as a source. Offeror must provide the above requested information. After review of the responses to this sources sought notice, a solicitation announcement may be published in the near future. Responses to this sources sought announcement are not considered adequate responses to the solicitation announcement. All interested offerors will have to respond to the forthcoming solicitation announcement, in addition to responding to this sources sought notice. All interested parties must be registered with System for Award Management (SAM) at https://www.sam.gov in order to be eligible for award of Government contracts. DISCLAIMER This RFI is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. | Market Research | 339113 | No Set-Aside | 09/14/2026 | 09/17/2026 | - | |
Enterprise Reprocessing of Non-Critical Single Use Devices (SUDs) RFI Number: 36C24E26Q0115 Release Date: August 28, 2026 Response Due Date: September 11, 2026 Point of Contact: Brett Cook Disclaimer and Purpose This is a Request for Information (RFI) issued by the Department of Veterans Affairs (VA) solely for market research and planning purposes in accordance with Federal Acquisition Regulation (FAR) Part 10, Market Research. This RFI does not constitute a solicitation (Request for Proposal, Request for Quotation, or Invitation for Bids), does not commit the Government to any contract or acquisition strategy, and does not obligate VA to award a contract now or in the future. No entitlement to payment of direct or indirect costs or charges by the Government will arise as a result of contractor responses to this RFI or the Government s use of such information. Any future procurement will be conducted in accordance with the FAR and the VA Acquisition Regulation (VAAR), including applicable VAAR provisions implementing the Veterans First Contracting Program and other socioeconomic requirements. Responses to this RFI may inform VA s acquisition planning, including potential small business or Veterans First set aside decisions, contract type, and performance-based acquisition approaches, but will not be used as evaluation criteria for any future solicitation. Proprietary and business sensitive information should be clearly marked; VA will handle such information in accordance with applicable laws and regulations. Executive Summary The Department of Veterans Affairs, America s largest integrated healthcare system, is exploring enterprise-wide adoption of FDA cleared third party reprocessing and reutilization of non-critical single use medical devices (SUDs). VA s objectives are to achieve significant cost savings, measurable medical waste reduction, and the highest possible patient safety through robust, scalable, and innovative reprocessing partnerships. To support rigorous acquisition planning and a defensible Independent Government Cost Estimate (IGCE), respondents must provide comprehensive cost and technical information for pilot phase, phased deployment, and full enterprise implementation. VA will prioritize evidence-based safety, interoperability with VA systems, digital integration, supplier diversity (including Veterans First participation), Section 508 accessibility, and a commitment to continuous improvement. This RFI is issued under FAR Part 10 and applicable VAAR provisions governing VA acquisition planning and market research. 1. Strategic Context and Objectives The VA is committed to: Reducing cost and optimizing resource utilization through safe, compliant reprocessing of non critical SUDs. Lowering environmental impact and regulated medical waste. Supporting digital transformation and supply chain modernization. Maximizing value, safety, and effectiveness in patient care for non critical applications. Advancing sustainability, supplier diversity, Veterans First participation, and Section 508 accessibility. Respondents should describe how their solutions align with these objectives and support performance-based acquisition and outcome focused contracting strategies consistent with FAR guidance. 2. Background VA is considering enterprise-wide solutions to reprocess non - critical SUDs (a representative list is provided in Appendix A) and seeks insights, outcomes, and recommendations from vendors serving government, military, or large integrated delivery networks. Robust cost estimates and evidence-based performance data are essential to support VA s business case evaluation, IGCE development, and acquisition planning under FAR/VAAR. 3. RFI Scope VA seeks market input on capabilities, approaches, and pricing models that could inform a future acquisition of enterprise non critical SUD reprocessing services. Areas of interest include: End-to-end collection, secure logistics , chain of custody, and tracking of non critical SUDs from VA facilities (see Appendix A for device types). FDA-cleared reprocessing, cleaning/disinfection, functional validation, relabeling, and safe release for reuse of non critical SUDs. Systems interoperability with VA informatics, supply chain, and EHR platforms, including adherence to Federal and VA standards for data protection and accessibility (e.g., Section 508). Training, onboarding, and change management for VA staff handling non critical SUDs. Environmental and financial impact measurement and transparent reporting specific to non critical SUDs. Detailed cost/pricing models and phased deployment estimates including pilot phase, a multi-year phased implementation resulting in full system implementation. These cost/pricing models should include annualized and cumulative scenarios to inform IGCE development and contract type selection. Data security, adverse event management, recall procedures, and regulatory compliance. Full scale enterprise ramp up, scalability, continuity, supplier diversity, and risk mitigation plans. Commitment to innovation, continuous improvement, and client engagement. 4. Key Definitions and Abbreviations Non-critical SUD: Device intended for one-patient/one-procedure use, contacting only intact skin (not mucous membranes/sterile body sites). FDA-cleared reprocessor: Third-party vendor with FDA 510(k)/PMA for reprocessing non-critical SUDs. QMS:Â Quality Management System (e.g., ISO 13485). CAPA: Corrective and Preventive Action. Section 508:Â Federal requirement for accessibility. IGCE: Independent Government Cost Estimate. Other acronyms/terms as used herein. 5. Information Requested Please organize your response according to the sections below and reference relevant non-critical SUDs (see Appendix A). Responses should not exceed 20 pages, plus optional appendices. Clearly identify proprietary information and any data that should be treated as business sensitive. Throughout your submission, provide sufficient detail, data, and explanation to allow VA to prepare an IGCE and to assess potentially appropriate contract types and risk allocations under FAR. A. Executive Summary Briefly describe your organization, capabilities, and your vision for VA s non-critical SUD reprocessing program. B. Regulatory Compliance & Quality Keep your existing bullets, and add: Identify any experience with federal healthcare or VA contracts and describe how you ensured compliance with FAR/VAAR requirements, quality standards, and applicable agency policies (no contract numbers needed). Provide FDA clearance documentation for all non-critical SUDs you are authorized to reprocess. Provide a list of non-critical SUDs you are not authorized to reprocess, explaining the rationale for not reprocessing these items. Include your QMS certifications (e.g., ISO 13485), audit/inspection history (last 5 years), and CAPA process. Describe how your Quality Management System and CAPA processes support performance-based contracting, measurable outcomes, and potential quality assurance surveillance by the Government in accordance with FAR principles. Provide sample device labels and chain-of-custody/logistics reports for representative non-critical SUDs. State readiness to comply with VA policies and update your status in response to regulatory changes. Describe anticipated challenges and solutions for addressing non-standard business processes (such as variations in device handling, workflow, collection, and onsite management) and the existence of multiple software systems/platforms across VA points of care. Specify how you will assess, adapt to, and mitigate the risks associated with these process and IT system variations during implementation and system integration. Explain how your proposed risk mitigation strategies for these variations will inform or alter your approach to phased deployment, including pilot planning and scaling to full enterprise adoption. C. Technical Approach, Workflow, and Interoperability Outline your non-critical SUD collection, sorting, logistics, and chain-of-custody system for VA s national footprint. Describe all tracking (barcoding, RFID, UDI), relabeling, and cycle management practices specifically for non-critical SUDs. Explain interoperability and data exchange with VA enterprise platforms (supply chain, EHR), including Section 508 accessibility and dashboard/reporting features. Attach a sample device tracking and utilization report for non-critical products. Identify any Government furnished property, data, or integration support you anticipate would be needed and how you would protect such assets in accordance with federal requirements. D. Reprocessing, Functional Validation, and Safety Detail all validated cleaning/disinfection, functional testing, and packaging processes for non-critical SUDs. Include evidence of device equivalency, validation studies, and sample performance metrics specific to non-critical SUDs. Explain recall, adverse event response, and reporting practices. Provide safety outcome data and case studies from similar non-critical SUD reprocessing in large integrated systems. E. Implementation, Training, and Change Management Detail your onboarding and ongoing education/training program for clinical, sterile processing, and supply chain staff specific to non-critical SUD handling and processes. Provide sample training materials or access to digital learning modules (508-compliant). Explain your approach for pilot/phased rollouts and scaling across VA regions for non-critical SUDs. Attach references and contact info for government or large-provider implementations involving non-critical SUDs. Describe how your implementation approach supports continuity of operations and minimizes disruption to clinical services in a federal healthcare environment. F. Environmental & Economic Outcomes (Evidence and Cost Estimate) Provide a detailed cost estimate for your proposed non-critical SUD reprocessing solutions. Break out: Per-device reprocessing costs (by SUD type and by volume tier, both collection and return-to-service); Up-front/recurring program costs (training, IT, logistics, account management); Any expected implementation/set-up costs (for pilot and system scale); Cost escalation formulas, savings guarantees, discount/volume thresholds, warranty/recall cost handling; Monetized environmental/waste savings estimates (if possible). Provide pilot-scale cost estimates and phased, 1-year-through-3-year total cost projections based on: Proposed pilot size (VA sites and device types), Anticipated adoption rates, Logistics/transport assumptions, Full deployment scenarios appropriate for VA enterprise-wide adoption. Include sample cost worksheets or templates and summarize cost drivers and price adjusters VA should consider for IGCE. Quantify, using anonymized/de-identified client case studies, total and average annual costs, and cost-avoidance/savings realized by other large health system/federal clients. Explain major cost drivers, assumptions, and contingencies to help VA assess cost realism and reasonableness and to inform selection of contract type (e.g., fixed price , IDIQ, or other structures consistent with FAR). G. Scalability, Timeline, and Supply Chain Risk Mitigation Describe your ability to scale processing operations nationwide for VA s anticipated non-critical SUD demand, including current capacity and expansion plans. Provide a timeline and milestones for scaling to full VA demand (with volume/phasing at each stage). Offer recommendations for phased implementation (by site, region, or device), including onboarding schedule. Identify key supply chain and operational risks (e.g., labor, logistics, materials, regulatory, collection variability) and provide mitigation strategies, disaster recovery, and business continuity plans. Include annualized and cumulative cost projections for each phase of proposed scale-up, highlighting cost inflection points associated with geographic expansion or device portfolio growth. Include examples of successful, rapid scale-up for other large integrated/federal clients related to non-critical SUDs. Describe how performance against these plans is tracked and reported. Identify any risks or dependencies that could affect contract performance and describe mitigation strategies that would be important for VA to consider in developing performance requirements and quality assurance measures. H. Data Security, Privacy, and Cybersecurity Detail your cybersecurity, privacy, HIPAA/HITECH, FISMA/FedRAMP compliance and security protocols for VA data exchange and device tracking related to non-critical SUDs. Provide evidence of third-party penetration testing and certifications where applicable. Confirm all reports, portals, and digital tools are or can be made Section 508 compliant. Describe any experience complying with VA-specific cybersecurity or privacy requirements (if applicable), including Authority to Operate (ATO) processes or similar activities. I. Contracting, Supplier Diversity, and Socioeconomic Participation Summarize your business model, contract types (fixed price, IDIQ, etc.), and service-level agreements for non-critical SUD reprocessing. Include a clear pricing model and breakdown for all contract types, with detailed pilot, interim, and full deployment price schedules. Describe any cost implications or incentives for inclusion of small/veteran-owned businesses as subcontractors. Summarize your preferred business/contract models for non-critical SUD reprocessing (e.g., firm fixed price, IDIQ, performance-based arrangements), including how you structure service level agreements, incentives, and remedies. Describe how your pricing model could be adapted to support VA s potential use of small business or Veterans First set asides, including approaches to teaming or subcontracting that maintain transparency and auditability. State your status (if any) as a Service-Disabled Veteran Owned Small Business (SDVOSB), Veteran Owned Small Business (VOSB), or other small/socioeconomic category, and describe your approach to meeting VA/VAAR socioeconomic subcontracting goals and Veterans First priorities. Describe any cost implications or incentives associated with inclusion of VOSB/SDVOSB and other small or disadvantaged businesses as subcontractors or teaming partners. J. Continuous Improvement, Innovation, and Roadmap Provide your roadmap for ongoing improvement, new non-critical device category addition, and technological innovation. Share frameworks for collaborative improvement, feedback cycles, and clinical engagement. K. Pilot / Proof of Concept Participation Your current section already supports phased acquisition and risk reduction activities that are consistent with FAR market research and acquisition planning practices. You may add one clarifier: Indicate willingness and best practices for a VA pilot or POC on non-critical SUDs, including proposed metrics, risk management, conversion to full implementation, and pilot-specific cost projections. Indicate whether your proposed pilot or POC construct could readily transition into a competitive procurement under FAR/VAAR and identify any constraints or considerations VA should plan for. L. Attachments Please find attached Appendix A MSPV Categories and Ready Matches. These are VA Medical Surgical Prime Vendor (MSPV) items and the associated categories active on the national product list that have been identified as having potential reprocessed equivalents. Please identify which items in Appendix A have a reprocessed equivalent. Also, please identify additional non-critical single use devices in your reprocessed item catalog for the VA s review and consideration. | Market Research | 339113 | No Set-Aside | 08/28/2026 | 09/11/2026 | - | |
Enterprise Reprocessing of Non-Critical Single Use Devices (SUDs) RFI Number: 36C24E26Q0115 Release Date: August 28, 2026 Response Due Date: September 11, 2026 Point of Contact: Brett Cook Disclaimer and Purpose This is a Request for Information (RFI) issued by the Department of Veterans Affairs (VA) solely for market research and planning purposes in accordance with Federal Acquisition Regulation (FAR) Part 10, Market Research. This RFI does not constitute a solicitation (Request for Proposal, Request for Quotation, or Invitation for Bids), does not commit the Government to any contract or acquisition strategy, and does not obligate VA to award a contract now or in the future. No entitlement to payment of direct or indirect costs or charges by the Government will arise as a result of contractor responses to this RFI or the Government s use of such information. Any future procurement will be conducted in accordance with the FAR and the VA Acquisition Regulation (VAAR), including applicable VAAR provisions implementing the Veterans First Contracting Program and other socioeconomic requirements. Responses to this RFI may inform VA s acquisition planning, including potential small business or Veterans First set aside decisions, contract type, and performance-based acquisition approaches, but will not be used as evaluation criteria for any future solicitation. Proprietary and business sensitive information should be clearly marked; VA will handle such information in accordance with applicable laws and regulations. Executive Summary The Department of Veterans Affairs, America s largest integrated healthcare system, is exploring enterprise-wide adoption of FDA cleared third party reprocessing and reutilization of non-critical single use medical devices (SUDs). VA s objectives are to achieve significant cost savings, measurable medical waste reduction, and the highest possible patient safety through robust, scalable, and innovative reprocessing partnerships. To support rigorous acquisition planning and a defensible Independent Government Cost Estimate (IGCE), respondents must provide comprehensive cost and technical information for pilot phase, phased deployment, and full enterprise implementation. VA will prioritize evidence-based safety, interoperability with VA systems, digital integration, supplier diversity (including Veterans First participation), Section 508 accessibility, and a commitment to continuous improvement. This RFI is issued under FAR Part 10 and applicable VAAR provisions governing VA acquisition planning and market research. 1. Strategic Context and Objectives The VA is committed to: Reducing cost and optimizing resource utilization through safe, compliant reprocessing of non critical SUDs. Lowering environmental impact and regulated medical waste. Supporting digital transformation and supply chain modernization. Maximizing value, safety, and effectiveness in patient care for non critical applications. Advancing sustainability, supplier diversity, Veterans First participation, and Section 508 accessibility. Respondents should describe how their solutions align with these objectives and support performance-based acquisition and outcome focused contracting strategies consistent with FAR guidance. 2. Background VA is considering enterprise-wide solutions to reprocess non - critical SUDs (a representative list is provided in Appendix A) and seeks insights, outcomes, and recommendations from vendors serving government, military, or large integrated delivery networks. Robust cost estimates and evidence-based performance data are essential to support VA s business case evaluation, IGCE development, and acquisition planning under FAR/VAAR. 3. RFI Scope VA seeks market input on capabilities, approaches, and pricing models that could inform a future acquisition of enterprise non critical SUD reprocessing services. Areas of interest include: End-to-end collection, secure logistics , chain of custody, and tracking of non critical SUDs from VA facilities (see Appendix A for device types). FDA-cleared reprocessing, cleaning/disinfection, functional validation, relabeling, and safe release for reuse of non critical SUDs. Systems interoperability with VA informatics, supply chain, and EHR platforms, including adherence to Federal and VA standards for data protection and accessibility (e.g., Section 508). Training, onboarding, and change management for VA staff handling non critical SUDs. Environmental and financial impact measurement and transparent reporting specific to non critical SUDs. Detailed cost/pricing models and phased deployment estimates including pilot phase, a multi-year phased implementation resulting in full system implementation. These cost/pricing models should include annualized and cumulative scenarios to inform IGCE development and contract type selection. Data security, adverse event management, recall procedures, and regulatory compliance. Full scale enterprise ramp up, scalability, continuity, supplier diversity, and risk mitigation plans. Commitment to innovation, continuous improvement, and client engagement. 4. Key Definitions and Abbreviations Non-critical SUD: Device intended for one-patient/one-procedure use, contacting only intact skin (not mucous membranes/sterile body sites). FDA-cleared reprocessor: Third-party vendor with FDA 510(k)/PMA for reprocessing non-critical SUDs. QMS:Â Quality Management System (e.g., ISO 13485). CAPA: Corrective and Preventive Action. Section 508:Â Federal requirement for accessibility. IGCE: Independent Government Cost Estimate. Other acronyms/terms as used herein. 5. Information Requested Please organize your response according to the sections below and reference relevant non-critical SUDs (see Appendix A). Responses should not exceed 20 pages, plus optional appendices. Clearly identify proprietary information and any data that should be treated as business sensitive. Throughout your submission, provide sufficient detail, data, and explanation to allow VA to prepare an IGCE and to assess potentially appropriate contract types and risk allocations under FAR. A. Executive Summary Briefly describe your organization, capabilities, and your vision for VA s non-critical SUD reprocessing program. B. Regulatory Compliance & Quality Keep your existing bullets, and add: Identify any experience with federal healthcare or VA contracts and describe how you ensured compliance with FAR/VAAR requirements, quality standards, and applicable agency policies (no contract numbers needed). Provide FDA clearance documentation for all non-critical SUDs you are authorized to reprocess. Provide a list of non-critical SUDs you are not authorized to reprocess, explaining the rationale for not reprocessing these items. Include your QMS certifications (e.g., ISO 13485), audit/inspection history (last 5 years), and CAPA process. Describe how your Quality Management System and CAPA processes support performance-based contracting, measurable outcomes, and potential quality assurance surveillance by the Government in accordance with FAR principles. Provide sample device labels and chain-of-custody/logistics reports for representative non-critical SUDs. State readiness to comply with VA policies and update your status in response to regulatory changes. Describe anticipated challenges and solutions for addressing non-standard business processes (such as variations in device handling, workflow, collection, and onsite management) and the existence of multiple software systems/platforms across VA points of care. Specify how you will assess, adapt to, and mitigate the risks associated with these process and IT system variations during implementation and system integration. Explain how your proposed risk mitigation strategies for these variations will inform or alter your approach to phased deployment, including pilot planning and scaling to full enterprise adoption. C. Technical Approach, Workflow, and Interoperability Outline your non-critical SUD collection, sorting, logistics, and chain-of-custody system for VA s national footprint. Describe all tracking (barcoding, RFID, UDI), relabeling, and cycle management practices specifically for non-critical SUDs. Explain interoperability and data exchange with VA enterprise platforms (supply chain, EHR), including Section 508 accessibility and dashboard/reporting features. Attach a sample device tracking and utilization report for non-critical products. Identify any Government furnished property, data, or integration support you anticipate would be needed and how you would protect such assets in accordance with federal requirements. D. Reprocessing, Functional Validation, and Safety Detail all validated cleaning/disinfection, functional testing, and packaging processes for non-critical SUDs. Include evidence of device equivalency, validation studies, and sample performance metrics specific to non-critical SUDs. Explain recall, adverse event response, and reporting practices. Provide safety outcome data and case studies from similar non-critical SUD reprocessing in large integrated systems. E. Implementation, Training, and Change Management Detail your onboarding and ongoing education/training program for clinical, sterile processing, and supply chain staff specific to non-critical SUD handling and processes. Provide sample training materials or access to digital learning modules (508-compliant). Explain your approach for pilot/phased rollouts and scaling across VA regions for non-critical SUDs. Attach references and contact info for government or large-provider implementations involving non-critical SUDs. Describe how your implementation approach supports continuity of operations and minimizes disruption to clinical services in a federal healthcare environment. F. Environmental & Economic Outcomes (Evidence and Cost Estimate) Provide a detailed cost estimate for your proposed non-critical SUD reprocessing solutions. Break out: Per-device reprocessing costs (by SUD type and by volume tier, both collection and return-to-service); Up-front/recurring program costs (training, IT, logistics, account management); Any expected implementation/set-up costs (for pilot and system scale); Cost escalation formulas, savings guarantees, discount/volume thresholds, warranty/recall cost handling; Monetized environmental/waste savings estimates (if possible). Provide pilot-scale cost estimates and phased, 1-year-through-3-year total cost projections based on: Proposed pilot size (VA sites and device types), Anticipated adoption rates, Logistics/transport assumptions, Full deployment scenarios appropriate for VA enterprise-wide adoption. Include sample cost worksheets or templates and summarize cost drivers and price adjusters VA should consider for IGCE. Quantify, using anonymized/de-identified client case studies, total and average annual costs, and cost-avoidance/savings realized by other large health system/federal clients. Explain major cost drivers, assumptions, and contingencies to help VA assess cost realism and reasonableness and to inform selection of contract type (e.g., fixed price , IDIQ, or other structures consistent with FAR). G. Scalability, Timeline, and Supply Chain Risk Mitigation Describe your ability to scale processing operations nationwide for VA s anticipated non-critical SUD demand, including current capacity and expansion plans. Provide a timeline and milestones for scaling to full VA demand (with volume/phasing at each stage). Offer recommendations for phased implementation (by site, region, or device), including onboarding schedule. Identify key supply chain and operational risks (e.g., labor, logistics, materials, regulatory, collection variability) and provide mitigation strategies, disaster recovery, and business continuity plans. Include annualized and cumulative cost projections for each phase of proposed scale-up, highlighting cost inflection points associated with geographic expansion or device portfolio growth. Include examples of successful, rapid scale-up for other large integrated/federal clients related to non-critical SUDs. Describe how performance against these plans is tracked and reported. Identify any risks or dependencies that could affect contract performance and describe mitigation strategies that would be important for VA to consider in developing performance requirements and quality assurance measures. H. Data Security, Privacy, and Cybersecurity Detail your cybersecurity, privacy, HIPAA/HITECH, FISMA/FedRAMP compliance and security protocols for VA data exchange and device tracking related to non-critical SUDs. Provide evidence of third-party penetration testing and certifications where applicable. Confirm all reports, portals, and digital tools are or can be made Section 508 compliant. Describe any experience complying with VA-specific cybersecurity or privacy requirements (if applicable), including Authority to Operate (ATO) processes or similar activities. I. Contracting, Supplier Diversity, and Socioeconomic Participation Summarize your business model, contract types (fixed price, IDIQ, etc.), and service-level agreements for non-critical SUD reprocessing. Include a clear pricing model and breakdown for all contract types, with detailed pilot, interim, and full deployment price schedules. Describe any cost implications or incentives for inclusion of small/veteran-owned businesses as subcontractors. Summarize your preferred business/contract models for non-critical SUD reprocessing (e.g., firm fixed price, IDIQ, performance-based arrangements), including how you structure service level agreements, incentives, and remedies. Describe how your pricing model could be adapted to support VA s potential use of small business or Veterans First set asides, including approaches to teaming or subcontracting that maintain transparency and auditability. State your status (if any) as a Service-Disabled Veteran Owned Small Business (SDVOSB), Veteran Owned Small Business (VOSB), or other small/socioeconomic category, and describe your approach to meeting VA/VAAR socioeconomic subcontracting goals and Veterans First priorities. Describe any cost implications or incentives associated with inclusion of VOSB/SDVOSB and other small or disadvantaged businesses as subcontractors or teaming partners. J. Continuous Improvement, Innovation, and Roadmap Provide your roadmap for ongoing improvement, new non-critical device category addition, and technological innovation. Share frameworks for collaborative improvement, feedback cycles, and clinical engagement. K. Pilot / Proof of Concept Participation Your current section already supports phased acquisition and risk reduction activities that are consistent with FAR market research and acquisition planning practices. You may add one clarifier: Indicate willingness and best practices for a VA pilot or POC on non-critical SUDs, including proposed metrics, risk management, conversion to full implementation, and pilot-specific cost projections. Indicate whether your proposed pilot or POC construct could readily transition into a competitive procurement under FAR/VAAR and identify any constraints or considerations VA should plan for. L. Attachments Please find attached Appendix A MSPV Categories and Ready Matches. These are VA Medical Surgical Prime Vendor (MSPV) items and the associated categories active on the national product list that have been identified as having potential reprocessed equivalents. Please identify which items in Appendix A have a reprocessed equivalent. Also, please identify additional non-critical single use devices in your reprocessed item catalog for the VA s review and consideration. | Market Research | 339113 | No Set-Aside | 08/28/2026 | 09/11/2026 | - |
Additional Details
Solicitation Number
36C24E26Q0058_0001
Archive Date
Nov 3, 2026
Office Address
PITTSBURGH, PA, 15212